Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

OssDsign

5.87 SEK

-2.17 %

Less than 1K followers

OSSD

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for OssDsign

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue35.741.4133.944.546.544.045.1180.2
EBITDA-9.8-12.3-49.4-12.7-6.9-5.5
EBIT-9.8-12.3-49.4-12.7-6.9-5.5-21.6-46.8
EBIT-%-27.5 %-29.6 %-36.9 %-28.5 %-14.9 %-12.6 %-47.8 %-26.0 %
Profit before taxes-9.8-12.6-49.1-14.7-7.9-5.6-22.0-50.2
Net income-9.8-13.1-49.7-14.6-8.3-5.8-22.3-51.0
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.